ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:27 am Sale |
2023-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
ADAGE CAPITAL PARTNERS GP LLC | 29,086 1.550% |
-67,701 (-69.95%) |
Filing |
| 2023-02-02 4:45 pm Purchase |
2023-01-23 | 13G | BioXcel Therapeutics, Inc. BTAI |
ADAGE CAPITAL PARTNERS GP LLC | 96,787 5.530% |
96,787 (New Position) |
Filing |